Antisense inhibition of 5-hydroxytryptamine(2a) receptor induces an antidepressant-like effect in mice

Molecular Pharmacology

Volumn 52, Issue 6, 1997, Pages 1056-1063

  Sibille, Etienne ^a   Sarnyai, Zoltan ^b   Benjamin, Daniel ^c   Gal, Judit ^a   Baker, Harriet ^a   Toth, Miklos ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTISENSE OLIGONUCLEOTIDE; SEROTONIN 2A ANTAGONIST;

ANIMAL MODEL; ARTICLE; DEPRESSION; DOWN REGULATION; DRUG EFFECT; DRUG RECEPTOR BINDING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031451187     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.6.1056     Document Type: Article

References (40)

1. Loo, H., and T. Brochier. Long-term treatment with antidepressive drugs. Ann. Med. Psychol. (Paris) 153:190-197 (1995).
2. Blackshear, M. A., and E. Sanders-Bush. Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J. Pharmacol. Exp. Ther. 221:303-308 (1982).
3. Peroutka, S. J., and S. H. Snyder. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science (Washington D. C.) 210:88-90 (1980).
4. 3H]spiroperidol by chronic treatment with the antidepressant amitriptyline. J. Pharmacol. Exp. Ther. 215:582-587 (1980).
5. 2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br. J. Pharmacol. 83:235-242 (1984).
6. Hadcock, J. R., H. Y. Wang, and C. C. Malbon. Agonist-induced destabilization of beta-adrenergic receptor mRNA: attenuation of glucocorticoid-induced up-regulation of beta-adrenergic receptors. J. Biol. Chem. 264: 19928-19933 (1989).
7. Collins, S., M. G. Caron, and R. J. Lefkowitz. From ligand binding to gene expression: new insights into the regulation of G-protein-coupled receptors. Trends Biochem Sci. 17:37-39 (1992).
8. 3H]serotonin binding and functional studies in the rat. Brain Res. 189:449-457 (1980).
9. 2 receptor mRNA levels. Eur. J. Pharmacol. 207:169-172 (1991).
10. Wahlestedt, C. Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol. Sci. 15:42-46 (1994).
11. Pazos, A., A. Probst, and J. M. Palacios. Serotonin receptors in the human brain. IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21:123-139 (1987).
12. Weiser, M., H. Baker, T. C. Wessel, and T. H. Joh. Differential spatial and temporal gene expression in response to axotomy and deafferentation following transection of the medial forebrain bundle. J. Neurosci. 13:3472-3484 (1993).
13. Toth, M., J. Grimsby, G. Buzsaki, and G. P. Donovan. Epileptic seizures caused by inactivation of a novel gene, jerky, related to centromere binding protein-B in transgenic mice. Nat. Genet. 11:71-75 (1995).
14. Porsolt, R. D., A. Bertin, and M. Jalfre. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229:327-336 (1977).
15. Pellow, S., P. Chopin, S. E. File, and M. Briley. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14:149-167 (1985).
16. Donovan, G. P., C. Harden, J. Gal, L. Ho, E. Sibille, R. Trifiletti, L. J. Gudas, and M. Toth. Sensitivity to Jerky gene dosage underlies epileptic seizures in mice. J. Neurosci. 17:4562-4569 (1997).
17. Julius, D. Molecular biology of serotonin receptors. Annu. Rev. Neurosci. 14:335-360 (1991).
18. 1c receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI). Neurosci. Lett. 115:74-80 (1990).
19. Bedard, P., and C. J. Pycock. 'Wet-dog' shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacology 16:663-670 (1977).
20. Biegon, A., and M. Israeli. Quantitative autoradiographic analysis of the effects of electroconvulsive shock on serotonin-2 receptors in male and female rats. J. Neurochem. 48:1386-1391 (1987).
21. 2 receptor-mediated head shakes but not brain C-fos induction. Neuropharmacology 35:303-313. (1996).
22. Porsolt, R. D., A. Bertin, N. Blavet, M. Deniel, and M. Jalfre. Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur. J. Pharmacol. 57:201-210 (1979).
23. Borsini, F. Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev. 19:377-395 (1995).
24. Schmidt, C. J., C. K. Sullivan, and G. M. Fadayel. Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine. J. Neurochem. 62:1382-1389 (1994).
25. Cullinan, W. E., J. P. Herman, D. F. Battaglia, H. Akil, and S. J. Watson. Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience 64:477-505 (1995).
26. Wilson, W. A., and A. V. Escueta. Common synaptic effects of pentylenetetrazol and penicillin. Brain Res. 72:168-171 (1974).
27. Velasco, F., M. Velasco, F. Estrada-Villanueva, and J. P. Machado. Specific and nonspecific multiple unit activities during the onset of pentylenetetrazol seizures. I. Intact animals. Epilepsia 16:207-214 (1975).
28. Mirski, M. A., and J. A. Ferrendelli. Anterior thalamic mediation of generalized pentylenetetrazol seizures. Brain Res. 399:212-223. (1986).
29. Toth, M., and T. Shenk. Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: modulation of transcription. Mol. Pharmacol. 45:1095-1100 (1994).
30. 2 binding site after chronic administration of agonists and antagonists. Neuropharmacology 25:1267-1271 (1986).
31. Young, E. A., S. Akana, and M. F. Dallman. Decreased sensitivity to glucocorticoid fast feedback in chronically stressed rats. Neuroendocrinology 51:536-542 (1990).
32. West, A. P. Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Prog. Neuropsychopharmacol. Biol. Psychiatry 14:863-877 (1990).
33. 2 receptors and serotonergic axons in rat neocortex. Brain Res. 453:315-328 (1988).
34. 2-activated interneuron. Brain Res. 506:62-69 (1990).
35. Morilak, D. A., S. J. Garlow, and R. D. Ciaranello. Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain. Neuroscience 54:701-717 (1993).
36. 2A receptor antagonist. Eur. J. Pharmacol. 259:137-141 (1994).
37. Reyntjens, A., Y. G. Gelders, M. L. J. A. Hoppenbrouwers, and G. Vanden Busche. Thymosthenic effects of ritanserin (R55667), a centrally acting serotonin-S2 receptor blocker. Drug Dev. Res. 8:205-211 (1986).
38. Busatto, G. F., and R. W. Kerwin. Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia. J. Psychopharmacol. 11:3-12 (1997).
39. 2 receptors. Psychopharmacology (Berl) 112 (Suppl. 1):S40-S54 (1993).
40. 2A antagonist with a favorable central nervous system safety profile. J. Pharmacol. Exp. Ther. 277:968-981 (1996).